This suggests that IGFBP-3 may either utilize multiple mechanisms for its anti-tumor actions depending upon the cellular environment or the observed IGFBP-3 interaction with cytoplasmic/nuclear partners may not represent major IGFBP-3 anti-tumor signaling. This evidence concerns the gene IGFBP3 and neoplasm.